In attempt to further enhance the effectiveness of the immunotherapy of bladder cancer, including its more advanced stages, and potentially other malignancies, we evaluated the impact of BCG on local production of the chemokines attracting the desirable effector CD8+ T cells and undesirable MDSCs and Treg cells. The gene discussed is CD8A; the disease is urinary bladder carcinoma.